Cancer Biomarkers Market Size & Share To Surpass $48.52 Billion By 2028|BioMérieux Inc. (France), INOVIQ (Australia), Abbott(US)

Market Overview:
The Cancer Biomarkers Market size is anticipated to reach USD 48.52 billion by 2028 from an estimated USD 16.56 billion in 2021, growing at a CAGR of 16.6% globally.

Cancer biomarkers are biological molecules that are created by tumor cells or by human tissues in reaction to cancer. These molecules are then tested and assessed as a sign of malignant processes occurring within the body. Cancer biomarkers are widely employed in the diagnosis and treatment of cancer patients. The World Health Organization (WHO) estimates that cancer will be the leading cause of death globally in 2020, accounting for almost one in every six fatalities. Biomarkers are utilized in follow-up surveillance and for the early diagnosis of potential recurring disease in cancer patients who have had curative surgery. Molecular biomarkers are also used as part of standard diagnostic procedures as part of ongoing developments in cancer diagnosis.

Read More: https://introspectivemarketresearch.com/reports/cancer-biomarkers-market/

Market Dynamics:
Driver:
Over the forecast period, the market growth is anticipated to be driven by the rising incidence of cancer. After skin cancer, breast cancer is the second most frequent type of cancer in the United States. Men and women can both develop breast cancer. Breast cancer is exceedingly uncommon among men, who are more likely to develop it than women. For instance, based on information provided by Breastcancer.org, an estimated 287,850 new cases of invasive breast cancer and 51,400 new cases of non-invasive (in situ) breast cancer will each be diagnosed in women in the United States in March 2022.

Opportunities:
Governments from both emerging and developed countries are heavily funding research and development initiatives for the creation of cancer biomarkers. Additionally, market participants from the public and private sectors are working together to discover cancer biomarkers. Over the anticipated period, all of the aforementioned factors are developing profitable opportunities for the growth and development of the global cancer biomarkers market.

Click Here To Get a Sample Copy of Cancer Biomarkers Market Report:
https://introspectivemarketresearch.com/request/16460

Segmentation Analysis Of Cancer Biomarkers Market
By Biomarker Type, protein biomarker is expected to account for the largest market share in the forecasted period. The protein biomarker is used for the early detection of the breast as well as colonic cancer. Breast cancer and colon cancer are the most common type of cancer and major cause of death around the world.

By Cancer Type, breast cancer is projected to have the maximum market share in the cancer biomarker market during the analysis period. Breast cancer is one of the most common cancers in women. Breast cancer occurs due to various reasons such as genetic mutation, being overweight, reproductive history, and alcohol drinking. The risk of breast cancer increases the age.

By End-Users, the Academic & Cancer Research Institutes are expected to have the highest market share in cancer biomarkers during the projected timeframe. Owing to the growing prevalence of cancer, rising research and development of advanced treatments.

By Cancer Biomarkers
• Genetic Biomarkers
• Protein Biomarkers
• Other Cancer Biomarkers

By Cancer Type
• Lung Cancer
• Breast Cancer
• Kidney Cancer
• Liver Cancer
• Others

By End Users
• Academic & Cancer Research Institutes
• Hospitals
• Cancer Diagnostic Laboratories
• Ambulatory Surgical Centers

Regional Analysis Of Cancer Biomarkers Market
North America is the dominant region in the cancer biomarkers market owing to the growing number of cancer patients. The increasing number of tobacco, and alcohol consumption, unhealthy food habits, genetic mutation, hormonal imbalance, growing demand for early diagnosis, and the rising geriatric population in this region. These are the common causes of cancer. For instance, there were 32.51 million Americans smoked cigarettes in the year 2020. Statista stated that in 2020 North America had the highest 12-month rate of the prevalence of cancer. Thus, the incidence of cancer in this region is increased. In the United State, there were236 thousand lung cancer cases diagnosed in 2021. Growing awareness about the treatment of cancer among American people the organizations increasing their investment in research and development of biomarkers for cancer treatment. Growing population with cancer and rising investment in the development of biomarkers people the growth of the cancer biomarkers market in the North American region.

By Region
• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
• Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
• South America (Brazil, Argentina, Rest of SA)

Ask here for more customization@
https://introspectivemarketresearch.com/custom-research/16460

Top Key Players Covered In Cancer Biomarkers Market
• BioMérieux Inc. (France)
• INOVIQ (Australia)
• Bio-Rad Laboratories Inc. (California)
• Abbott(US)
• Becton, Dickinson, and Company (US)
• Merck KgaA (Germany)
• QIAGEN (Germany)
• Thermo Fisher Scientific Inc. (US)
• CENTOGENE N.V. (Germany)
• PerkinElmer Inc. (US)
• Siemens Healthcare Private Limited (Germany), and other major players.

Key Industry Development In The Cancer Biomarkers Market
• In April 2021, F. Hoffmann-La Roche Ltd. (Switzerland), established Elecsys Anti-p53 immunoassay for the diagnosis of various cancer types.
• In December 2020, FDA approves the NGS-based companion diagnostic of Thermo Fisher Scientific (US) for EGFR Exon20 insertion mutant non-small cell lung cancer tumor tissue.

Limited Time Offer | Buy this Premium Research Report with Exclusive Discount and Immediate Delivery@
https://introspectivemarketresearch.com/discount/16460

Table Of Content:
Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application
Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing
Chapter 5: Cancer Biomarkers Market by Type
 5.1 Cancer Biomarkers Market Overview Snapshot and Growth Engine
 5.2 Cancer Biomarkers Market Overview
 5.3 Neurostimulation
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Neurostimulation: Geographic Segmentation
 5.4 Imaging Modalities
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Imaging Modalities: Geographic Segmentation
 5.5 Neurological Implants
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Neurological Implants: Geographic Segmentation
 5.6 Cranial Surface Measurement
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Cranial Surface Measurement: Geographic Segmentation
 5.7 Others
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size (2016-2028F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Others: Geographic Segmentation
Continue………

You Can Buy This Report From Here:
https://introspectivemarketresearch.com/checkout/?user=1&_sid=16460

Our Latest Category-Related Reports:
https://introspectivemarketresearch.com/reports/liquid-biopsy-market/
https://introspectivemarketresearch.com/reports/point-of-care-diagnostics-market/
https://introspectivemarketresearch.com/reports/blood-urea-nitrogen-diagnostics-market/

Contact us:
Introspective Market Research
3001 S King Drive,
Chicago, Illinois
60616 USA
Ph no: +1-773-382-1047
Email : sales@introspectivemarketresearch.com
LinkedIn | Twitter | Facebook

About us:
Introspective Market Research (introspectivemarketresearch.com) is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

This release was published on openPR.